Lataa...
Prevention of ER-Negative Breast Cancer
The successful demonstration that the selective estrogen receptor modulators (SERMs) tamoxifen and raloxifene reduce the risk of breast cancer has stimulated great interest in using drugs to prevent breast cancer in high-risk women. In addition, recent results from breast cancer treatment trials sug...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4068124/ https://ncbi.nlm.nih.gov/pubmed/19213564 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|